CURATECH.NS,0P0000C64V,0
Quality, valuation, momentum and financial trend all sit near 0/100 — no single factor dominates.
Fair valueOur blended model reads CURATECH.NS,0P0000C64V,0 as a Strong Sell at 0/100. At ₹71.79 there isn't enough clean financial data for a confident fair-value estimate, so we hold back an intrinsic verdict. It's sitting close to its 52-week low of ₹69.46. It clears 0 of 4 investability checks, with momentum 0 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
1-year price
EOD · 2026-07-3152-week range
-78.70% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Strong Sell0Piotroski F-score 2/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
Not enough data to run the investability checklist.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
- Weak Piotroski score (2/9).
CURATECH.NS,0P0000C64V,0 — frequently asked questions
Is CURATECH.NS,0P0000C64V,0 a buy, hold or sell?
StocksWizard currently rates CURATECH.NS,0P0000C64V,0 (CURATECH) a Strong Sell, based on a blended score of 0/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
How has CURATECH.NS,0P0000C64V,0's share price performed?
CURATECH.NS,0P0000C64V,0 is down 23% over three months, and last traded at ₹71.79. Past performance doesn't predict future returns.
More in Other
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.